The food contaminant deoxynivalenol provokes metabolic impairments resulting in non-alcoholic fatty liver (NAFL) in mice

Sci Rep. 2020 Jul 21;10(1):12072. doi: 10.1038/s41598-020-68712-w.

Abstract

The ribotoxin deoxynivalenol (DON) is a trichothecene found on cereals responsible for mycotoxicosis in both humans and farm animals. DON toxicity is characterized by reduced food intake, diminished nutritional efficiency and immunologic effects. The present study was designed to further characterize the alterations in energy metabolism induced by DON intoxication. We demonstrated that acute DON intoxication triggered liver steatosis associated with an altered expression of genes related to lipids oxidation, lipogenesis and lipolysis. This steatosis was concomitant to anorexia, hypoglycemia and a paradoxical transient insulin release. DON treatment resulted also in stimulation of central autonomic network regulating sympathetic outflow and adrenaline and glucocorticoids secretion. Furthermore, an increased expression of genes linked to inflammation and reticulum endoplasmic stress was observed in the liver of DON-treated mice. Finally, we propose that lipids mobilization from adipose tissues (AT) induced by DON intoxication drives hepatic steatosis since (1) genes encoding lipolytic enzymes were up-regulated in AT and (2) plasma concentration of triglycerides (TGs) and non-esterified fatty acids were increased during DON intoxication. Altogether, these data demonstrate that DON induced hormonal and metabolic dysregulations associated with a spectrum of hepatic abnormalities, evocative of a non-alcoholic fatty liver disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animal Feed* / analysis
  • Animals
  • Biomarkers
  • Cytokines
  • Disease Models, Animal
  • Endoplasmic Reticulum Stress
  • Energy Metabolism / drug effects*
  • Fatty Acids / metabolism
  • Food Contamination*
  • Glycogen
  • Hormones / metabolism
  • Immunohistochemistry
  • Inflammation Mediators
  • Lipid Metabolism
  • Lipolysis
  • Liver / metabolism
  • Male
  • Mice
  • Non-alcoholic Fatty Liver Disease / etiology*
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Non-alcoholic Fatty Liver Disease / pathology
  • Oxidation-Reduction
  • Trichothecenes / adverse effects*

Substances

  • Biomarkers
  • Cytokines
  • Fatty Acids
  • Hormones
  • Inflammation Mediators
  • Trichothecenes
  • Glycogen
  • deoxynivalenol